Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3885147 | 0.92 | ABCB1 (0.77) | ABCB1ABCG2 | |
| SCHEMBL4048095 | 0.91 | ABCB1 (0.71) | ABCB1ABCG2 | |
| SCHEMBL4045945 | 0.90 | ABCB1 (0.70) | ABCB1ABCG2 | |
| SCHEMBL4045320 | 0.90 | ABCB1 (0.70) | ABCB1ABCG2 | |
| SCHEMBL7173150 | 0.90 | ABCG2 (0.80) | ABCB1ABCG2 | |
| SCHEMBL3885910 | 0.90 | ABCB1 (0.83) | ABCB1ABCG2 | |
| SCHEMBL4042173 | 0.89 | ABCB1 (0.68) | ABCB1ABCG2 | |
| SCHEMBL4042085 | 0.89 | ABCB1 (0.68) | ABCB1ABCG2 | |
| SCHEMBL5211256 | 0.89 | ABCB1 (0.72) | ABCB1ABCG2 | |
| SCHEMBL4040129 | 0.88 | ABCB1 (0.71) | ABCB1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934276-B1 | ANTHRANILIC ACID DERIVATIVES AS MULTI DRUG RESISTANCE MODULATORS | XENOVA LTD (GB) | 2003-12-17 | — | — | EP | claimed |
| US-6218393-B1 | IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG | XENOVA LIMITED (GB) | 2001-04-17 | — | — | US | claimed |
| EP-0934276-A1 | ANTHRANILIC ACID DERIVATIVES AS MULTI DRUG RESISTANCE MODULATORS | XENOVA LIMITED (GB) | 1999-08-11 | — | — | EP | claimed |
| EP-0934276-B1 | ANTHRANILIC ACID DERIVATIVES AS MULTI DRUG RESISTANCE MODULATORS | XENOVA LTD (GB) | 2003-12-17 | — | — | EP | disclosed |
| US-6218393-B1 | IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG | XENOVA LIMITED (GB) | 2001-04-17 | — | — | US | disclosed |